Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2008

View Archived Issues

Responses to nemifitide seen in patients with severe, refractory depression

Volociximab-gemcitabine combination feasible in metastatic pancreatic cancer

Satisfactory therapeutic window of Micromet's BiTE antibody muS-110

Small molecule CCR3 antagonist shows preclinical efficacy for the treatment of asthma

New agents for treating neurological disorders described in recent patent literature

Once-daily mesalamine for active ulcerative colitis now available in Canada

New anticancer agents disclosed in recent patents

Theratechnologies reviews strategic alternatives to enhance shareholder value

Topigen initiates European phase II trial of TPI-ASM-8 in asthma patients

Lipid reports favorable results from preclinical study of delipidated autologous virus vaccine

Phase II trial demonstrates Davanat's benefits in combination with other chemotherapeutics

Ipsen withdraws application to EMEA for extension of indication for Nutropin AQ

Oasmia receives final advice from EMEA regarding phase III program for Paclical

FDA grants priority review for Millennium's Velcade for multiple myeloma

DOR BioPharma achieves 2-year stability milestone for its ricin toxin vaccine

FDA issues nonapprovable letter to Impax for Vadova for Parkinson's disease

Tigris Pharmaceuticals initiates phase I study of AFP-464 for treatment of solid tumors

Phosphagenics announces results from preclinical study of APA-01 and atorvastatin

First patients treated in Cytori's stem and regenerative cell heart attack study

Banyu obtains additional indication approval for Singulair in allergic rhinitis

Somaxon submits NDA for Silenor, a drug candidate for insomnia therapy

Novel agents for arthritic disorders disclosed in recent patents

GlaxoSmithKline obtains approval for Amerge in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...